These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Echinocandins: the newest class of antifungals. Sucher AJ; Chahine EB; Balcer HE Ann Pharmacother; 2009 Oct; 43(10):1647-57. PubMed ID: 19724014 [TBL] [Abstract][Full Text] [Related]
5. Micafungin: the US perspective. Zaas AK; Steinbach WJ Expert Rev Anti Infect Ther; 2005 Apr; 3(2):183-90. PubMed ID: 15918776 [TBL] [Abstract][Full Text] [Related]
6. Micafungin (Mycamine) for fungal infections. Med Lett Drugs Ther; 2005 Jun; 47(1211):51-2. PubMed ID: 15961968 [TBL] [Abstract][Full Text] [Related]
7. Dalbavancin: a new option for the treatment of gram-positive infections. Lin SW; Carver PL; DePestel DD Ann Pharmacother; 2006 Mar; 40(3):449-60. PubMed ID: 16507624 [TBL] [Abstract][Full Text] [Related]
8. A clinical review of echinocandins in pediatric patients. VandenBussche HL; Van Loo DA Ann Pharmacother; 2010 Jan; 44(1):166-77. PubMed ID: 20009006 [TBL] [Abstract][Full Text] [Related]
9. Activities of micafungin against 315 invasive clinical isolates of fluconazole-resistant Candida spp. Messer SA; Diekema DJ; Boyken L; Tendolkar S; Hollis RJ; Pfaller MA J Clin Microbiol; 2006 Feb; 44(2):324-6. PubMed ID: 16455878 [TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness analysis of antifungal prophylaxis in patients undergoing hematopoietic stem cell transplantation. Schonfeld W; Wang Cheng J; Tong KB; Seifeldin R Clin Ther; 2008 May; 30(5):964-73. PubMed ID: 18555943 [TBL] [Abstract][Full Text] [Related]
12. The echinocandin micafungin: a review of the pharmacology, spectrum of activity, clinical efficacy and safety. Wiederhold NP; Lewis JS Expert Opin Pharmacother; 2007 Jun; 8(8):1155-66. PubMed ID: 17516879 [TBL] [Abstract][Full Text] [Related]
13. Micafungin versus fluconazole for prophylaxis against invasive fungal infections during neutropenia in patients undergoing hematopoietic stem cell transplantation. van Burik JA; Ratanatharathorn V; Stepan DE; Miller CB; Lipton JH; Vesole DH; Bunin N; Wall DA; Hiemenz JW; Satoi Y; Lee JM; Walsh TJ; Clin Infect Dis; 2004 Nov; 39(10):1407-16. PubMed ID: 15546073 [TBL] [Abstract][Full Text] [Related]
14. A randomized, double-blind, parallel-group, dose-response study of micafungin compared with fluconazole for the treatment of esophageal candidiasis in HIV-positive patients. de Wet N; Llanos-Cuentas A; Suleiman J; Baraldi E; Krantz EF; Della Negra M; Diekmann-Berndt H Clin Infect Dis; 2004 Sep; 39(6):842-9. PubMed ID: 15472817 [TBL] [Abstract][Full Text] [Related]
15. The pharmacokinetics and safety of micafungin, a novel echinocandin, in premature infants. Heresi GP; Gerstmann DR; Reed MD; van den Anker JN; Blumer JL; Kovanda L; Keirns JJ; Buell DN; Kearns GL Pediatr Infect Dis J; 2006 Dec; 25(12):1110-5. PubMed ID: 17133155 [TBL] [Abstract][Full Text] [Related]
16. Micafungin sodium, the second of the echinocandin class of antifungals: theory and practice. Vehreschild JJ; Cornely OA Future Microbiol; 2006 Aug; 1(2):161-70. PubMed ID: 17661660 [TBL] [Abstract][Full Text] [Related]
17. [Antifungal activity and clinical efficacy of micafungin sodium (Funguard)]. Ikeda F Nihon Yakurigaku Zasshi; 2003 Oct; 122(4):339-44. PubMed ID: 14501170 [TBL] [Abstract][Full Text] [Related]
18. Role of micafungin in the antifungal armamentarium. Ikeda F; Tanaka S; Ohki H; Matsumoto S; Maki K; Katashima M; Barrett D; Aoki Y Curr Med Chem; 2007; 14(11):1263-75. PubMed ID: 17504145 [TBL] [Abstract][Full Text] [Related]
19. Micafungin for the prophylaxis and treatment of Candida infections. Fritz JM; Brielmaier BD; Dubberke ER Expert Rev Anti Infect Ther; 2008 Apr; 6(2):153-62. PubMed ID: 18380597 [TBL] [Abstract][Full Text] [Related]